Further evidence for epidemiological virulence of Escherichia coli.

Further evidence for epidemiological virulence of Escherichia coli. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Further evidence for epidemiological virulence of Escherichia coli. Abstract Text:

R H Winterbauer,M Turck,R G Petersdorf,

Further evidence for epidemiological virulence of Escherichia coli. Publishing Authors By Initials

RH Winterbauer,M Turck,RG Petersdorf,

For similar biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: virulence research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: virulence research

PUBMED ID PMID:

MEDLINE DATE:

Further evidence for epidemiological virulence of Escherichia coli. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Antimicrobial agents and chemotherapy

VOLUME: 5

Page Numbers: 71-6

Journal Abbreviation:

ISSN:

DAY: 21

MONTH: 02

YEAR: 1965

Further evidence for epidemiological virulence of Escherichia coli. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 116415

Further evidence for epidemiological virulence of Escherichia coli. Keywords Mesh Terms:

KEYWORDS: Virulence

MESH TERMS: epidemiology

Chemical & Substance for Abstract: Further evidence for epidemiological virulence of Escherichia coli. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Further evidence for epidemiological virulence of Escherichia coli.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Antimicrob Agents Chemother (B

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Further evidence for epidemiological virulence of Escherichia coli Related Publications

• Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis.
• Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.
• EVALUATION OF AMPICILLIN IN GRAM-NEGATIVE INFECTIONS.
• External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.
• FURTHER STUDIES WITH AMPICILLIN.
• Further evidence for epidemiological virulence of Escherichia coli.
• How to cope with the doctor glut in the United States.
• Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation.
• Immunogenomics of unrelated hematopoietic cell transplantation.
• Optimal HLA matching in hematopoietic cell transplantation.
• Susceptibility of Enterobacteriaceae to nitrofurantoin correlated with eradication of bacteriuria.
• The declining applicant pool.
• The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.